Janine M. Davies

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 562 citations · Full text

Medicine, Oncology, Pharmacology +11

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Treatment of Metastatic Colorectal Cancer

Janine M. Davies, Richard M. Goldberg · Seminars in Oncology · 2011 · 79 citations

Medicine, Oncology, Surgery +12

Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion

Henry T. Lynch, Douglas L. Riegert‐Johnson, Carrie Snyder et al. · The American Journal of Gastroenterology · 2011 · 61 citations

Medicine, Genetics, Oncology +17

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing

Hui‐Li Wong, Kevin Yang, Yaoqing Shen et al. · Molecular Case Studies · 2017 · 45 citations · Full text

Medicine, Molecular Genetics, Oncology +17